Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea and Singapore Regulators Sign Trade MOU For Drugs, Devices

This article was originally published in PharmAsia News

Executive Summary

SEOUL - Korea's FDA and Singapore's Health Sciences Authority have signed a memorandum of understanding as part of their efforts to ensure the safety, quality and efficacy of health products traded between the two countries
Advertisement

Related Content

U.S. FDA Suggests Multi-layered Approach To Combat Counterfeit Drugs
More Talks Needed With China and Japan For Cooperation In Sharing Clinical Data - Korea FDA Official
Korea Targets Biologics, Devices, Health Care Among Economic Growth Projects For Next Decade
Korea Targets Biologics, Devices, Health Care Among Economic Growth Projects For Next Decade
Advertisement
UsernamePublicRestriction

Register

SC075098

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel